Clearance of Minimal Residual Disease (MRD) in patients with 17p-CLL after Allogeneic HCT: Results of the Non-interventional Study of EBMT & ERIC

Author(s):
Schetelig, J.; Hoek, J.; Stilgenbauer, S.; Bornhauser, M.; Andersen, N.S.; Fox, C.; Lenhoff, S.; Bunjes, D.; Volin, L.; Shimoni, A.; Schroyens, W.; Gelder, M. van; Biezen, A. van; Wreede, L. de; Witte, T. de; Kroger, N.; Dreger, P.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-03-31
Language
English
Is part of
Bone Marrow Transplantation (2015), Vol. 50, p. S108-S108
hdl
1887/107974